Showing results (1141-1150 of 1,622) with videos related to

Sort By:
Pageof 163
Annals of the New York Academy of Sciences|February 17, 2000
Pharmacology of FMRFamide-related peptides in helminthsT G Geary, N J Marks, A G Maule, et al.
Neuron|October 23, 2008
In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptorsRyan M Drenan, Sharon R Grady, Paul Whiteaker, et al.
ACS Applied Materials & Interfaces|August 15, 2013
Systematic investigation of organic photovoltaic cell charge injection/performance modulation by dipolar organosilane interfacial layersCharles Kiseok Song, Alicia C White, Li Zeng, et al.
Journal of the American Chemical Society|October 29, 2014
Slip-stacked perylenediimides as an alternative strategy for high efficiency nonfullerene acceptors in organic photovoltaicsPatrick E Hartnett, Amod Timalsina, H S S Ramakrishna Matte, et al.
JAMA Dermatology|April 29, 2017
Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed SolutionAravind Krishnan, Tim Xu, Susan Hutfless, et al.
ACS Applied Materials & Interfaces|February 17, 2016
Tunable Radiation Response in Hybrid Organic-Inorganic Gate Dielectrics for Low-Voltage Graphene ElectronicsHeather N Arnold, Cory D Cress, Julian J McMorrow, et al.
Frontiers in Pharmacology|October 17, 2017
TC299423, a Novel Agonist for Nicotinic Acetylcholine ReceptorsTeagan R Wall, Brandon J Henderson, George Voren, et al.
International Journal of Obesity (2005)|September 21, 2017
Widespread prevalence of a CREBRF variant amongst Māori and Pacific children is associated with weight and height in early childhoodS D Berry, C G Walker, K Ly, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 13, 2019
Simultaneous Bottom-Up Interfacial and Bulk Defect Passivation in Highly Efficient Planar Perovskite Solar Cells using Nonconjugated Small-Molecule ElectrolytesDing Zheng, Ruixiang Peng, Gang Wang, et al.
The Lancet. Neurology|April 5, 2008
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trialWilliam J Marks, Jill L Ostrem, Leonard Verhagen, et al.
Pageof 163